Top Markets
#1 Black Phoenix Black Phoenix +21,375.11%
#2 Nesa Nesa +738.28%
#3 ADO Protocol ADO Protocol +95.15%
#4 Cortex Cortex +91.80%
#5 Ontology Gas Ontology Gas +89.55%
#6 Kinesis Silver Kinesis Silver +54.21%
#7 OpenEden OpenEden +34.72%
#8 Biconomy Biconomy +30.16%
#9 Magma Finance Magma Finance +25.39%
#10 QuantixAI QuantixAI +23.21%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Viking Therapeutics, Inc. Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

VKTX
Rank in Stocks #4247
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Share Price
$34.24
Market Cap
$3.99B
Change (1 day)
0.21%
Change (1 year)
31.49%
Country
US
Trade Viking Therapeutics, Inc. (VKTX)

Category

Healthcare
Stock price history for Viking Therapeutics, Inc. (VKTX)
Highest end of day price: $33.94 on 2026-08-01

Lowest end of day price: $8.59 on 2015-04-01
Stock price history of Viking Therapeutics, Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -9.08%
2025 -20.83%
2024 152.59%
2023 215.71%
2022 16.84%
2021 -21.08%
2020 -20.48%
2019 -10.51%
2018 130.53%
2017 246.93%
2016 -60.36%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.63 41.96%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.56%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $146.79 493.55%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 6.25%
CH